KPTI
USDKaryopharm Therapeutics Inc. Common Stock
$5.240-0.145 (-2.693%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$5.385
High
$5.391
Low
$5.240
Volume
0.07M
Company Fundamentals
Market Cap
89.3M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.20M
Exchange
NMS
Currency
USD
52-Week Range
Low $3.51Current $5.240High $14.25
Related News
Analyst Upgrades
RBC Capital Maintains Outperform on Karyopharm Therapeutics, Lowers Price Target to $19
RBC Capital analyst Brian Abrahams maintains Karyopharm Therapeutics with a Outperform and lowers the price target from $30 to $19.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.